Table 1_NSAID use may decrease serum Klotho levels.docx by Jingchao Yan (14079168)

“…Subgroup analyses did not reveal any statistically significant interactions.</p>Conclusion<p>Contrary to previous speculations, the use of NSAIDs is associated with a decrease in serum Klotho levels.…”

Effect of Molecular Structure on the B3LYP-Computed HOMO–LUMO Gap: A Structure −Property Relationship Using Atomic Signatures by Ahmed Mohamed (628889)

“…The use of atomic Signatures as molecular descriptors successfully inferred correlations between different structural motifs and <i>E</i>_gap. The atomic fragments containing π-bonds in various aromatic compounds were found to be the most significant atomic Signatures, explaining nearly 50% of the variance in the data, with regression coefficients that decreased <i>E</i>_gap. …”

Conceptual framework to guide the study. by Resham B. Khatri (10949429)

“…</p><p>Conclusions</p><p>Marginalized women experience lower uptake of routine maternity care visits and higher discontinuation along the antenatal through to ponstantal period, creating significant equity gaps in Nepal. The increasing trend of deliveries in private HFs, particularly deliveries by elective CS without maternity incentives could lead to financial hardship while seeking routine maternal health care. …”

Schematic representation of the study protocol. by Neng Pan (5262032)

Subjects:

Baseline characteristics. by Neng Pan (5262032)

Subjects:

Comparison within groups. by Neng Pan (5262032)

Subjects:

Comparison before and after the experiment in each group. by Neng Pan (5262032)

Subjects:

Data ste. by Neng Pan (5262032)

Subjects:

Comparison of data after the experiment. by Neng Pan (5262032)

Subjects:

Correlation diagram of each parameter in each group. by Neng Pan (5262032)

Subjects:

Recruitment process. by Neng Pan (5262032)

Subjects:

Comparison of post-experimental outcome measures. by Neng Pan (5262032)

Subjects:

Annual incidence of insomnia disorder (ICD-CODE: G47) Bar: rate of insomnia disorder relative to all patients; Line: average number of outpatient visits for patients with insomnia... by Mingee Choi (15250732)

Subjects:

Distribution of non-pharmacological treatment related to insomnia disorder (2002–2019). by Mingee Choi (15250732)

Subjects:

Detailed treatment status of patients who did not receive non-pharmacological treatment at first diagnosis but received it later. by Mingee Choi (15250732)

Subjects:

Mean interval from initial diagnosis to initiation of non-pharmacological treatment by year. by Mingee Choi (15250732)

Subjects:

General information of patient who diagnosis insomnia disorder (N = 518,119). by Mingee Choi (15250732)

Subjects:

Detailed treatment status of people who received non- pharmacological treatment at first diagnosis. by Mingee Choi (15250732)

Subjects:

Treatment at first diagnosis of insomnia disorder (%). by Mingee Choi (15250732)

Subjects:

S1 Data - by Jessica C. M. Hui (20370522)

“…Compared to the SD, the HFD and SDG models exhibited significantly increased and decreased contraction velocities and could be used as models of diarrhoea and constipation in DM, respectively, while the ED model showed comparatively little change in motility. …”